Evidence map›Paper›PMID 12878519›Full record

ArticleAntimicrobial agents and chemotherapy2003

MsrR, a putative cell envelope-associated element involved in Staphylococcus aureus sarA attenuation.

Jutta Rossi, Markus Bischoff, Akihito Wada, Brigitte Berger-Bächi

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. The Gram-Positive Bacterial Cell Wall.Microbiology spectrum · 2019
    Review
  8. Article
  9. Article
  10. Frontiers in cellular and infection microbiology · 2018
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Jutta RossiInstitute of Medical Microbiology, University of Zürich, CH-8028 Zürich, Switzerland.
Markus Bischoff
Akihito Wada
Brigitte Berger-Bächi
University of Zurich · CHNational Institute of Infectious Diseases · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel membrane-associated protein, MsrR, was identified in Staphylococcus aureus which affects resistance to methicillin and teicoplanin, as well as the synthesis of virulence factors. MsrR belongs to the LytR-CpsA-Psr family of cell envelope-related transcriptional attenuators and was shown to be inducible by cell wall-active agents, such as beta-lactams, glycopeptides, and lysostaphin. The expression of msrR peaked in the early exponential growth phase and decreased sharply thereafter. msrR mutants showed increased sarA transcription and an earlier and higher expression of RNAIII, resulting in altered expression of virulence factors such as alpha-toxin and protein A. These observations suggest that MsrR is a new component involved in sarA attenuation and the regulatory network controlling virulence gene expression in S. aureus.

Indexed as

Bacterial ProteinsAnti-Bacterial AgentsAutolysisBase SequenceCarrier ProteinsCell WallDNA PrimersDNA Transposable ElementsLuciferasesMembrane ProteinsMolecular Sequence DataMutationPhenotypePlasmidsRNA, BacterialStaphylococcus aureusAnti-Bacterial AgentsBacterial ProteinsCarrier ProteinsDNA PrimersDNA Transposable ElementsLuciferasesMembrane ProteinsMsrR protein, Staphylococcus aureusRNA, BacterialSarA protein, Staphylococcus aureusVirulence Factors

Identifiers

PMID12878519
PMCPMC166063
OpenAlexW2153861410

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.